Patents Assigned to Rinat Neuroscience Corp.
  • Methods For Idendifying Drug Targets And Modulators Of Neurons and Compositions Comprising The Same
    Publication number: 20070275374
    Abstract: The invention provides methods of identifying drug targets in dopaminergic and/or noradrenergic neurons and to the drug targets identified by such methods. This invention also provides a method of screening for agents that modulate dopaminergic neurons and/or noradrenergic neuron activity, function and/or drug target expression, and agents that bind drug targets and to kits for use in the methods described herein.
    Type: Application
    Filed: March 17, 2004
    Publication date: November 29, 2007
    Applicant: RINAT NEUROSCIENCE CORP.
    Inventors: Jan Grimm, Arnon Rosenthal
  • Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody
    Patent number: 7255860
    Abstract: The invention features methods and compositions for preventing or treating post-surgical pain by administering an anti-NGF antagonist antibody.
    Type: Grant
    Filed: October 8, 2003
    Date of Patent: August 14, 2007
    Assignee: Rinat Neuroscience Corp.
    Inventors: David L. Shelton, German J. Vergara
  • Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist
    Patent number: 7252822
    Abstract: The invention features methods and compositions for preventing or treating pain resulting from surgery or an incision by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
    Type: Grant
    Filed: October 8, 2003
    Date of Patent: August 7, 2007
    Assignee: Rinat Neuroscience Corp.
    Inventors: David L. Shelton, German J. Vergara
  • Methods for treating taxol-induced gut disorder
    Publication number: 20070014786
    Abstract: This invention relates to the field of taxol-induced gut disorder. More specifically, the invention relates to methods of treating taxol-induced gut disorder comprising administration of agonist anti-trkC antibody for the treatment, prevention, and/or amelioration of a symptom of taxol-induced gut disorder.
    Type: Application
    Filed: March 22, 2004
    Publication date: January 18, 2007
    Applicant: RINAT NEUROSCIENCE CORP.
    Inventor: David Shelton